Pharma-Bio Serv, Inc. financial data

Symbol
PBSV on OTC
Location
Dorado, PR
Fiscal year end
31 October
Latest financial report
10-Q - Q2 2025 - 15 Sep 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 661 % -7.09%
Debt-to-equity 20.3 % -18.7%
Return On Equity -0.68 % +88.3%
Return On Assets -0.56 % +87.8%
Operating Margin -7.17 % +34.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.9M shares -0.17%
Common Stock, Shares, Outstanding 22.9M shares -0.16%
Entity Public Float 13.6M USD 0%
Common Stock, Value, Issued 2.35K USD 0%
Weighted Average Number of Shares Outstanding, Basic 22.9M shares -0.15%
Weighted Average Number of Shares Outstanding, Diluted 22.9M shares -0.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.18M USD -14.8%
Cost of Revenue 6.3M USD -21.8%
Operating Income (Loss) -659K USD +44.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -113K USD +85.6%
Income Tax Expense (Benefit) -19.6K USD -137%
Net Income (Loss) Attributable to Parent -84.3K USD +90%
Earnings Per Share, Diluted 0 USD/shares -71.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.87M USD -79.8%
Marketable Securities, Current 6.77M USD +6.7%
Accounts Receivable, after Allowance for Credit Loss, Current 2.02M USD -22.5%
Assets, Current 13.2M USD -17.4%
Property, Plant and Equipment, Net 132K USD +623%
Operating Lease, Right-of-Use Asset 72.7K USD -69.6%
Other Assets, Noncurrent 226K USD +79.7%
Assets 13.6M USD -16.7%
Liabilities, Current 1.66M USD -12.7%
Accrued Income Taxes, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 1.66M USD -37%
Accumulated Other Comprehensive Income (Loss), Net of Tax 286K USD +12.8%
Retained Earnings (Accumulated Deficit) 10.5M USD -14.6%
Stockholders' Equity Attributable to Parent 11.9M USD -12.9%
Liabilities and Equity 13.6M USD -16.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -416K USD -23.6%
Net Cash Provided by (Used in) Financing Activities -1.74M USD -0.45%
Net Cash Provided by (Used in) Investing Activities -438K USD -108%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 23.5M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.56M USD -170%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.96M USD -39.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Operating Lease, Liability 194K USD -44%
Payments to Acquire Property, Plant, and Equipment 163K USD +14126%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52K USD +93.6%
Lessee, Operating Lease, Liability, to be Paid 379K USD -31.6%
Property, Plant and Equipment, Gross 828K USD +23.9%
Operating Lease, Liability, Current 71.4K USD -55.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 29.1K USD -83.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 175K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.82K USD -69.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 29.1K USD -83.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 1.68M USD +2.06%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%